Young Americans' Marijuana Use Increases with Legalization: Survey

Nov.29.2022
Young Americans' Marijuana Use Increases with Legalization: Survey
Legalization of marijuana in the US has led to a significant increase in young adults smoking, according to a new survey.

A recent survey conducted in the United States has revealed a sharp increase in the number of young people consuming marijuana, following its legalization in many parts of the country, including New York.


A Gallup Poll analysis has revealed that 26% of individuals aged 18 to 29 have used marijuana, compared to 17% in 2015.


According to a Gallup report, smoking rates among young people have dropped from 35% in 2003 to 25% a decade ago, and now stand at 12%, which is more than two times lower than before.


According to an analysis by Gallup, smoking rates have dramatically declined in the past 20 years, driven mainly by a decrease in smoking among young people, which is encouraging for public health officials. However, more young people are turning to marijuana, possibly due to its legalization in more states and its prevalence among youth compared to traditional smoking, along with the use of e-cigarettes.


Twenty-one states have legalized the recreational use of marijuana, including several populous states on the East and West Coasts. Other states, such as Florida and Pennsylvania, have legalized marijuana for medicinal purposes.


According to Gallup's analysis, it supports a recent study published in the journal "Addictive Behaviors" by Temple University researchers. The study claims that "after the legalization of recreational marijuana use, the monthly usage rate among adolescents and young adults increased." The researchers warned that there will be an increase in marijuana addiction or untreated "marijuana use disorders.


The study also found that "among young adults, higher rates of marijuana use were associated with lower rates of hospitalization for CUD treatment.


Opponents of marijuana legalization say that their concerns are now in the past.


Due to coordinated preventative efforts, marijuana usage has steadily decreased for several decades. However, the legalization and commercialization of marijuana are now threatening to undo these public health benefits. "Smart Approaches to Marijuana" President Kevin Sabet stated, "We also cannot ignore the fact that young people are starting to use new forms of marijuana, such as e-cigarettes and concentrated products, which are closely linked to severe mental health risks and higher rates of addiction.


However, supporters say that they are pleased that people can use it legally.


I am delighted to be a part of this process. I am passionate about changing the stigma around cannabis. There is a certain stigma, but culture is changing," said Nicholas Koury, who last week received one of the first licenses issued by the state of New York to open a cannabis dispensary in Manhattan. "The stigma is not necessarily accurate. Cannabis can help people's mental state and has medicinal value," he said.


According to a survey, 26% of people aged 18 to 29 have admitted to using marijuana, which is higher than the reported 17% in 2015.


Last week, New York issued its first round of 28 cannabis dispensary licenses and is now tackling a rapidly growing unlicensed and unregulated black market where Budagges and other top shops openly sell marijuana and cannabis edibles.


According to a Gallup survey, some young smokers appear to be turning to e-cigarettes or less toxic electronic cigarettes, with approximately 7% of US adults reporting using them in the past week.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

PMI Q2 Call: ZYN Growth, IQOS Pricing and a Diverging Global Tobacco Market
PMI Q2 Call: ZYN Growth, IQOS Pricing and a Diverging Global Tobacco Market
Philip Morris International’s second-quarter earnings call offered new detail on its smoke-free strategy. Management said it would increase U.S. investment behind nicotine pouch brand ZYN, keep IQOS focused on volume before stronger pricing, and use SENTIA, DELIA, LEVIA, VEEV and ZYN to manage tax and regulatory pressure across Japan and Europe. Analysts from Goldman Sachs, Morgan Stanley, UBS and other firms also pressed PMI on profitability, market share, cigarette resilience and the durability of its global transformation over coming quarters.
Jul.24
BAT Expands ITC Infotech Partnership Across Poland, Romania and India to Advance AI
BAT Expands ITC Infotech Partnership Across Poland, Romania and India to Advance AI
ITC Infotech has expanded its multi-year strategic technology partnership with British American Tobacco (BAT), providing technology services across Poland, Romania and India while continuing to support BAT's newly launched Future Capabilities Centre in India and existing technology hubs in Malaysia and Mexico. The companies said the agreement will focus on AI-enabled innovation, technology capability building and greater operational efficiency. The partnership also aligns with BAT's broader Fit2Win transformation programme, under which the group is expanding the use of external technology and business-services partners to simplify its global operating model.
Aug.13
AIR Invests $20 Million in Greentank, Deepening Capital Ties Across the Vape Supply Chain
AIR Invests $20 Million in Greentank, Deepening Capital Ties Across the Vape Supply Chain
Nasdaq-listed AIR Global has invested $20 million in preferred shares of Canadian vaporization technology company Greentank, deepening a partnership established in 2023. AIR gains a board nomination right, access to new technologies, enhanced commercial terms and long-term supply assurances, while retaining an option to increase its stake. Greentank’s Quantum Chip platform powers Crown Switch and forms part of AIR’s planned U.S. PMTA dossier, linking capital investment more closely with product technology, regulatory evidence and supply-chain control.
Special Report
Jul.29
Indiana’s Foreign-Made Vape Ban Takes Effect, Forcing Brands and Retailers to Adjust Supply Chains
Indiana’s Foreign-Made Vape Ban Takes Effect, Forcing Brands and Retailers to Adjust Supply Chains
A new Indiana law restricting the sale of foreign-made vape products has taken effect, requiring retailers to adjust inventory and sourcing practices. According to The Sun, WDRB and other reports, some local vape shops are reviewing product origins and supplier information to comply with the new requirements. The measure represents a broader shift in U.S. vape regulation, with oversight expanding beyond product authorization and sales rules toward manufacturing origin and supply-chain management.
Jul.24
JAMA Issues First U.S. Clinical Guidance on Vaping for Smoking Cessation, Urging Complete Switch From Cigarettes
JAMA Issues First U.S. Clinical Guidance on Vaping for Smoking Cessation, Urging Complete Switch From Cigarettes
JAMA has published a Special Communication offering systematic recommendations for U.S.-based clinicians on the use of nicotine e-cigarettes in adult smoking cessation. Developed by the Harm Reduction Workgroup of the Society for Research on Nicotine and Tobacco’s Treatment Research Network, the paper recommends including e-cigarettes alongside FDA-approved cessation medications in risk-benefit discussions. It cites high-certainty evidence that nicotine e-cigarettes achieve higher quit rates than nicotine replacement therapy and evidence suggesting efficacy comparable to highly effective medications such as varenicline and cytisine. For adults who choose vaping to quit, the authors recommend FDA-authorized products, sufficient nicotine delivery and a rapid, complete transition away from cigarettes rather than prolonged dual use.
Aug.13
DOJ Trade Fraud Task Force Tops $1 Billion in Cases, Putting Vape Supply Chains at Risk of Fraud Enforcement
DOJ Trade Fraud Task Force Tops $1 Billion in Cases, Putting Vape Supply Chains at Risk of Fraud Enforcement
According to the U.S. Department of Justice (DOJ), Fox News and other reports, the DOJ’s Trade Fraud Task Force (TFTF) has been linked to more than $1 billion in recoveries, penalties, forfeitures and publicly charged losses in less than one year. The task force focuses on trade fraud issues including country-of-origin fraud, illegal transshipment, false declarations and tariff evasion. While vape products are not the main source of the $1 billion figure, the industry’s reliance on global manufacturing and cross-border supply chains places it within broader U.S. trade enforcement scrutiny. The development suggests that U.S. oversight of cross-border vape products may increasingly extend beyond product authorization into import compliance, supply-chain transparency and corporate accountability.
Jul.23